Haoxi Health Technology Ltd key statistics and ratios
In fiscal 2026, Haoxi Health Technology Ltd had return on equity of -54.1%, an operating margin of -17.6%, debt equal to 1.6% of equity and a current ratio of 4.53. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|
| Gross margin | 4.0% | 7.3% | 5.7% | 2.8% | 1.1% |
| Operating margin | 1.7% | 4.2% | 3.5% | −6.1% | −17.6% |
| Net margin | 1.5% | 3.4% | 2.7% | 11.8% | −17.4% |
| Free-cash-flow margin | −4.2% | −3.3% | −1.7% | −10.2% | −4.7% |
| Return on equity | — | — | 20.1% | 27.1% | −54.1% |
| Return on assets | — | 21.7% | 12.9% | 20.9% | −44.2% |
| Asset turnover | — | 6.32 | 4.86 | 1.77 | 2.54 |
| Current ratio | — | 1.43 | 3.98 | 5.01 | 4.53 |
| Debt to equity | — | 50.3% | 10.9% | 11.0% | 1.6% |
| Interest cover (operating income ÷ interest) | — | 60.5x | 41.7x | n/m | n/m |
| Effective tax rate | 5.8% | 18.5% | 25.6% | 6.5% | — |
| R&D as % of revenue | 0.6% | 0.2% | 0.2% | 0.2% | 0.2% |
| Capital spending as % of revenue | 0.1% | 0.2% | 0.1% | 0.0% | 0.0% |
| Free cash flow ÷ net income | −279.7% | −94.6% | −62.2% | −86.6% | — |
Financial health
- Short-term assets cover short-term liabilities $17m of assets due within a year against $4m of liabilities due within a year.
- Short-term assets cover long-term liabilities $17m short-term assets against $0 of longer-dated liabilities.
- More cash than debt Cash or debt not separately reported. Not assessable.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
- Operating profit covers interest at least five times over Operating income of −$10m against $52,446 of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Cryo Cell International Inc statistics
- American Shared Hospital Services statistics
- Ridgetech Inc. statistics
- NRC Health statistics
- Airsculpt Technologies, Inc. statistics
Head to head: CCEL vs HAOAMS vs HAOHAO vs RDGT
More: Health Care Services stocks compared, Health Care sector, rankings of US companies